The full podcast can now be viewed at https://youtu.be/xmOpSZaBi1w.
We had tried to have YouTube correct the previously upload which only played the first 4 minutes of the 18 minute interview, but they were unable to do that and so we have been forced to re-upload the podcast.
We apologize again for any inconvenience that this may have caused you.
Jeffrey S. Vender, MD is Clinical Professor at the University Of Chicago, Pritzker School of Medicine. He is also Chairman of the clinical advisory committee to the Respiratory Compromise Institute.
The Respiratory Compromise Institute is a coalition of medical and safety organizations devoted to raising awareness about respiratory compromise. Members of the Respiratory Compromise Institute consist of representatives from leading medical and safety organizations:
- American Association for Respiratory Care
- American College of Chest Physicians
- American College of Emergency Physicians
- American Society of Anesthesiologists
- American Thoracic Society
- Canadian Society of Respiratory Therapists
- National Association of Clinical Nurse Specialists
- National Association of EMS Physicians
- National Association for Medical Direction of Respiratory Care
- Physician Patient Alliance for Health & Safety
- Society of Anesthesia & Sleep Medicine
- Society of Critical Care Medicine
- Society of Hospital Medicine
The Respiratory Compromise Institute defines respiratory compromise as “a potentially life threatening state of unstable respiratory health.” Respiratory Compromise “is a gradual, subtle imbalance in patient response that encompasses respiratory failure and arrest, with symptoms that manifest differently in each patient.”
Dr. Vender believes that “there’s been a lack of understanding of how to monitor better, or to recognize better, those patients at-risk.” He encourages clinicians to do “a better job of monitoring and understanding the drugs we use in those patients at risk, so we can reduce these complications.”
During the podcast, Dr. Vender discussed similarities with early stages of the campaign to raise awareness about sepsis:
No different then when the Surviving Sepsis Campaign was developed for sepsis managed. Irrespective of one’s perception of the materials provided or the evidence based medicine used, the Surviving Sepsis Campaign markedly increased clinician awareness of the problem for earlier diagnosis, much more acute intervention. And, today, whatever studies we look at the vast majority, even the control groups, for routine care have been markedly better as far as morbidity/mortality than the control groups of studies years gone by. And the reason for that is really just increased better care but more understanding and more awareness. Not necessarily a mandate of what to do.”
To read a transcript of the interview, please click here.